Early HCC treatment: a future strategy against interferon/miR-484 axis to revert precancerous lesions?
Abstract
No abstract available
Journal Articles
Gut
Year : 2016
Angélique GOUGELET : Connect in order to contact the contributor
https://www.hal.inserm.fr/inserm-02532895
Submitted on : Thursday, April 28, 2022-12:06:34 PM
Last modification on : Friday, March 24, 2023-2:53:26 PM
Long-term archiving on: Friday, July 29, 2022-6:59:29 PM
Dates and versions
Identifiers
- HAL Id : inserm-02532895 , version 1
- DOI : 10.1136/gutjnl-2016-311446
- PUBMED : 26944073
Cite
André Lechel, Angélique Gougelet. Early HCC treatment: a future strategy against interferon/miR-484 axis to revert precancerous lesions?. Gut, 2016, 65 (7), pp.1073-1074. ⟨10.1136/gutjnl-2016-311446⟩. ⟨inserm-02532895⟩
83
View
2
Download